UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. The companies were locked in...
International News
Australia’s Sigma Healthcare says in preliminary discussions over Boots acquisition
Australia’s Sigma Healthcare said on Wednesday that it had engaged in preliminary discussions regarding a potential acquisition of the British pharmacy chain Boots, following recent media speculation. The...
Activist Ancora builds stake in Ashland, pushes for sale
Activist Ancora Alternatives has built a significant stake in Ashland Inc and wants the U.S. specialty chemicals company to sell itself, arguing that a transaction could boost its share price by at least 30%, according...
UK’s Boots in talks for $10 billion sale as owners plan to scrap IPO plans, FT reports
Boots is in talks with the billionaire Weston family and Australian pharmacy group Sigma Healthcare over a $10 billion (£7.5 billion) sale that would see the British health and beauty retailer scrap its plans for a...
Starbucks mulls options for Japan business, including stake sale, Bloomberg reports
Starbucks is weighing options for its Japanese business, including a stake sale, Bloomberg News reported on Tuesday. A stake sale might be valued at ¥400 billion ($2.5 billion) to ¥500 billion, possibly attracting...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. Here are some details: The companies...
Bain Capital enters bidding war for Australia’s oOh!media after rival offers
Australian advertising firm oOh!media said on Tuesday it had received indicative takeover offers from Bain Capital and other financial sponsors, triggering a three-way bidding war with I Squared Capital and Pacific...
J&J to buy cancer drug technology developer Firefly Bio for $1 billion
Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. Firefly’s Firelink platform uses antibodies to deliver a protein...
Ingredion to buy UK’s Tate & Lyle for $3.6 billion
U.S. group Ingredion has struck a deal to buy Britain’s Tate & Lyle for £2.7 billion ($3.6 billion) in cash to create a leading speciality food and beverage ingredients company. The deal underscores how food...
Italy’s BPM invites MPS to $58 billion merger talks as Intesa, BPER weigh move
Italy’s Banco BPM said on Sunday it would invite Banca Monte dei Paschi di Siena to discuss a potential tie-up, with sources saying MPS had also attracted interest from Intesa Sanpaolo and BPER Banca. MPS, which...
United Airlines CEO says big merger unlikely after American rebuff, asset buys possible
United Airlines remains open to buying airport slots, gates or other assets if higher fuel prices put weaker rivals under pressure, but it is unlikely to pursue a major consolidation deal after its failed overture to...
Italy’s Intesa launches Monte dei Paschi takeover bid
Intesa Sanpaolo on Monday launched a bid to acquire all shares of Banca Monte Dei Paschi Di Siena (MPS), the company said. Intesa said its share-and-cash offer entailed a premium of 12.5% versus Monte dei...
